Jun 8, 2026 09:00AM
May 15, 2026 12:12PM
May 15, 2026 12:11PM
May 7, 2026 07:00AM
May 5, 2026 07:01AM
May 5, 2026 07:00AM
Mar 25, 2026 06:57AM H.C. Wainwright Reiterates Buy Rating on Amylyx Pharmaceuticals inc. (AMLX)
Mar 24, 2026 07:00AM
Mar 24, 2026 07:00AM
Mar 3, 2026 07:00AM
Dec 19, 2025 09:06AM
Dec 5, 2025 09:00AM
Dec 5, 2025 09:00AM
Nov 6, 2025 07:00AM Amylyx Pharmaceuticals Reports Third Quarter 2025 Financial Results
Oct 20, 2025 07:49AM
Oct 8, 2025 08:44AM
Aug 27, 2025 07:05AM
Aug 27, 2025 07:00AM
Aug 7, 2025 07:00AM
Jul 14, 2025 03:41PM
Jul 13, 2025 05:00PM Amylyx Pharmaceuticals Presents New Exploratory Analyses from Phase 2 and Phase 2b Clinical Trials of Avexitide in Post-Bariatric Hypoglycemia at ENDO 2025
Jul 8, 2025 07:00AM
Jun 17, 2025 05:17AM
Jun 3, 2025 07:01AM
Jun 3, 2025 07:00AM
May 12, 2025 07:01AM
May 12, 2025 07:00AM
May 8, 2025 07:00AM Amylyx Pharmaceuticals Reports First Quarter 2025 Financial Results
Apr 30, 2025 07:03AM
Apr 30, 2025 07:00AM
Mar 4, 2025 06:00AM
Jan 21, 2025 09:00AM
Jan 21, 2025 09:00AM
Jan 6, 2025 09:00AM
Dec 4, 2024 07:32AM Amylyx Pharmaceuticals (AMLX) Announces Pivotal Phase 3 LUCIDITY Trial Design for Avexitide
Dec 4, 2024 07:30AM
Nov 21, 2024 05:09AM
Nov 7, 2024 07:00AM
Oct 18, 2024 06:44AM
Oct 18, 2024 05:46AM
Oct 17, 2024 09:01AM
Oct 17, 2024 09:00AM Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 2 HELIOS Clinical Trial Demonstrating Sustained Improvements with AMX0035 in People Living with Wolfram Syndrome
Aug 8, 2024 07:00AM
Aug 2, 2024 09:00AM
Jul 11, 2024 10:30AM
Jul 10, 2024 07:00AM
Jul 10, 2024 07:00AM
May 9, 2024 07:00AM
Apr 10, 2024 09:02AM Amylyx Pharma (AMLX) Announces Interim Data From Ongoing Phase 2 HELIOS Trial Demonstrating Improvements in Pancreatic Function and Glycemic Control with AMX0035 in People with Wolfram Syndrome
Apr 10, 2024 09:00AM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All